Covenant Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Hold
0
-$1.46M 174
2022
Q4
Hold
0
83
2022
Q3
Hold
0
79

Other funds holding LLY

Covenant Asset Management's LLY Position: Q1 2026 in Review

Covenant Asset Management increased its Eli Lilly (LLY) stake by 1.5% in Q1 2026, buying an estimated $134K and bringing the position to 8,964 shares worth $8.24M. The position accounts for 1.24% of the portfolio, ranked #24.

Covenant Asset Management first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $10.8M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Covenant Asset Management held 8,964 shares of Eli Lilly worth $8.24M as of Q1 2026.
  • Covenant Asset Management bought 132 Eli Lilly shares in Q1 2026, an estimated $134K.
  • Eli Lilly made up 1.24% of Covenant Asset Management's portfolio in Q1 2026, its #24 holding.
  • Covenant Asset Management first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • Covenant Asset Management's Eli Lilly position peaked at $10.8M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Covenant Asset Management's 13F filing for Q1 2026, filed 14 Apr 2026.